TELA Bio, Inc. Lessee, Operating Lease, Liability, to be Paid, after Year Five
TELA Bio, Inc. (TELA) had Lessee, Operating Lease, Liability, to be Paid, after Year Five of $250.00 thousand as of 2024-12-31, per its 10-K filed 2025-03-21.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive · last filed 2025-03-21
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $250.00K.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $845.00K.
- 2023-09-30: Lessee, Operating Lease, Liability, to be Paid, after Year Five $165.00K.
- 2023-06-30: Lessee, Operating Lease, Liability, to be Paid, after Year Five $164.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, after Year Five | Lessee, Operating Lease, Liability, to be Paid, after Year Five as first filed |
|---|---|---|
| 2024-12-31 | $250.00K 10-K · filed 2025-03-21 | |
| 2023-12-31 | $845.00K 10-K · filed 2024-03-22 | |
| 2023-09-30 | $165.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $164.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $164.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $165.00K 10-K · filed 2023-03-23 | |
| 2022-09-30 | $165.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $165.00K 10-Q · filed 2022-08-11 | |
| 2021-12-31 | $500.00K 10-K · filed 2023-03-23 | $557.00K 10-K · filed 2022-03-23 |
| 2020-12-31 | $940.00K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |